Clinical trial
Memantine for Agitation in Dementia
NCT00371059 · East Kent Hospitals University NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00371059 |
|---|---|
| Title | Memantine for Agitation in Dementia |
| Official title | Pragmatic Randomized Control Trial of Memantine For Agitation In Dementia |
| Acronym | MAGD |
| Lead sponsor | East Kent Hospitals University NHS Foundation Trust, Other |
| Collaborators | University of Oxford Institute of Psychiatry, London University of London University College, London Indiana University School of Medicine |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | DEMENTIA |
| Intervention type | Drug |
| Interventions | Memantine, Placebo |
| Enrollment | 153 |
| Start date | Sep 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 1, 2006 |
| Last update posted | Apr 6, 2022 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: